How Much Does Peptide Therapy Cost Per Month?

Short answer: It depends entirely on the channel. Clinic-based programs typically run several hundred dollars per month and can exceed $1,000 once consultation fees, labs and supplies are included [attributed to clinic pricing pages retrieved August 2026 — ranges vary]. Supplement-format strips publish per-box prices of $99–$198, with no consultations and no hidden add-ons.

Peptide pricing is one of the most opaque corners of the wellness market. Clinics quote ranges after intake calls, research-vial sellers price without context, and almost nobody publishes all-in monthly math. This article does — using only documented figures, with the source and retrieval date attached. For the format trade-offs behind the numbers, see our strips vs injections cost comparison and the sublingual vs injectable pillar.

The three channels, and why they price differently

"Peptide therapy" prices mean nothing without the channel. There are three:

1. Clinic / telehealth programs (compounded injectables). This is what "peptide therapy" usually means in a search query: a prescriber, a compounding pharmacy, and an injectable. Clinic-based programs typically run several hundred dollars per month and can exceed $1,000 all-in [attributed to clinic pricing pages retrieved August 2026 — ranges vary by provider, compound, and region]. And this channel is where regulated access is heading: the July 2026 FDA advisory votes point toward prescriber/503A pathways formalizing, with rulemaking realistically into 2027 — the clinic price reflects that infrastructure.

2. Research-chemical vendors. Vials sold "for research use only," cheap per milligram and explicitly not for human use. The price difference is real, and so is the reason for it — see the sourcing-quality beat below.

3. Supplement-format strips. Packaged retail products with Supplement Facts panels, sold by the case rather than by prescription. InstaMed's retail storefront publishes per-box prices: $178 BPC-157, $138 GHK-Cu, $198 Thymosin Alpha-1, $118 NAD+, $145 Strength, $99 glutathione. The blends and newer formulas carry published prices too: SLEEP $89, NEURO $198, BOOST $199, KLOW $240, ULTRATRUTIDE $299, and PT-141+ $158.

The monthly-cost table

Numbers before narrative is the point: the channels aren't three prices for one thing — they're three different products with three different legal and quality postures.

The sourcing-quality beat: what the cheap vial price skips

The most useful quality data on the research-vial channel comes from a 2026 preprint by Mendias & Awan, which analyzed 6,441 direct-to-consumer research-peptide samples across 14 compounds and found that 41.6%–71.1% of samples failed basic quality criteria depending on the compound, with endotoxin contamination in 15% of samples (Mendias & Awan, 2026 preprint — not yet peer-reviewed, so treat as preliminary). It's the largest direct look at this supply chain anyone has published, preliminary or not. The RUO price is low partly because nobody in that chain is paying for verified quality, lawful status, or a label you can trust. Cheap and unverified is not a savings strategy; it's a different risk category.

What the per-month number hides

Consult fees are the real clinic cost driver. The peptide vial is often the minority of the monthly bill. Programs that quote a monthly figure sometimes exclude the initial consult, follow-ups, and labs. Ask for the all-in number.

Cost per milligram is not cost per absorbed dose. A strip can cost more per milligram than a vial and still be the cheaper absorbed dose — or the reverse. The bioavailability question is unresolved on both sides, and we won't repeat anyone's absorption percentage as fact. Our InstaMed pricing and value breakdown does the per-strip arithmetic box by box.

Prices are published for the whole line. All twelve SKUs carry retail prices, including the blends and PT-141+. Availability still moves, so confirm the live listing before ordering.

The honesty passage

The part that doesn't help us sell: we can't tell you peptide therapy is "worth it" at any price, because value depends on an evidence question this site refuses to fake. For most compounds in most formats, the human evidence is early, and the July 2026 advisory votes show regulators treating these as prescriber-channel drugs, not proven wellness products. The strip format we sell carries its own unresolved question — no published human pharmacokinetic data for sublingual delivery of most of these peptides. Price transparency we can give you; outcome promises, no one honestly can.

A concrete retail example

For an in-stock reference point: the BPC-157 sublingual strip is 500 mcg per strip, 20 per box, sold openly at $178 per box. Per the label's printed usage pattern, a box works out to roughly a month's supply [brand claim — unverified]. Unlike the gated SKUs, this one has a third-party certificate of analysis on file — a quality datum that belongs in any honest cost discussion, because five of the line's SKUs don't have one.

The bottom line

If you want the shortest honest answer: clinic therapy costs the most and buys prescriber oversight; research vials cost the least and skip verification entirely — at documented failure rates; strips sit in the middle with published prices, fixed doses, and nothing else to buy. For many people the strip channel is the one where the math, the routine, and the label all line up. Whatever you choose, verify the current figure on the product page or with the clinic — snapshots age.

---

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

This content is for educational purposes only and is not medical advice. Consult a licensed healthcare provider before starting any new product. Individual results vary.